Shares of McKesson Corp. MCK slipped 3.09% to $661.97 Monday, on what proved to be an all-around rough trading session for ...

McKesson has consistently grown ahead of the broader market in recent years. The stock’s steady earnings should attract ...

Deutsche Bank lowered the firm’s price target on McKesson (MCK) to $692 from $700 and keeps a Buy rating on the shares. The firm says the ...

Mizuho analyst Steven Valiquette raised the firm’s price target on McKesson (MCK) to $690 from $630 and keeps a Neutral rating on the shares.

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

Department now forecasts that the company will post earnings per share of $9.71 for the quarter, up from their prior forecast of $9.70. The consensus estimate for McKesson’s current full-year ...

Cherny now forecasts that the company will earn $41.75 per share for the year, down from their prior forecast of $41.98. The consensus estimate for McKesson’s current full-year earnings is $32. ...

McKesson has completed an $850 million acquisition of general ophthalmology and retina management services company PRISM ...

Whistleblower Omni Healthcare Inc. urged the US Supreme Court to reopen a False Claims Act suit alleging that McKesson Corp.

We recently published a list of Jim Cramer Reveals What’s Next After Tariffs & Discusses These 10 Stocks. In this article, we ...